CADL250117C18000
- 0.20
- 0.000.00%
Candel Therapeutics Newsroom
2025 Biotech Outlook: Small-cap Innovators Tackling Chronic and Rare Diseases | NASDAQ:CADL
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Candel Therapeutics(CADL.US) Director Buys US$7.5 Million in Common Stock
$Candel Therapeutics(CADL.US)$ Director Manning Paul B purchased 1.25 million shares of common stock on Dec 16, 2024 at an average price of $6 for a total value of $7.5 million.Source: Announcement
Candel Therapeutics Aims to Transform Cancer Outcomes | NASDAQ:CADL
Candel Therapeutics Analyst Ratings
H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Raises Target Price to $19
Express News | Candel Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $19 From $11
Candel Therapeutics Closes Securities Offering to Raise $92 Million
Press Release: Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
What's Going On With Candel Therapeutics Shares Friday?
Sector Update: Health Care Stocks Steady Premarket Friday
Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket
Top Premarket Decliners
Candel Therapeutics Shares Fall Premarket After Public Offering
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Candel Therapeutics: Offering Expected to Close On or About Dec. 16 >CADL
Express News | Candel Therapeutics Inc: Intends to Grant Underwriters a 30-Day Option to Purchase up to an Additional $12 Mln of Shares of Its Common Stock Offered
Press Release: Candel Therapeutics Announces $80 Million Proposed Public Offering